The need to look at antibiotic resistance from a health systems perspective

References

• Kaplan W, Laing R. Priority medicines for Europe and the world. Geneva: World Health Organization; 2004.
   Google Scholar
• World Health Organization. Everybody’s business–strengthening health systems to improve health outcomes: WHO’s framework for action. Geneva: World Health Organization; 2007.
   Google Scholar
• de Savigny D, Adam T. Systems thinking for health systems strengthening. Geneva: World Health Organization; 2009.
   Google Scholar
• Marais B, Crawford J, Iredell J, Ward M, Simpson S, Gilbert L, et al. One world, one health: beyond the Millennium Development Goals. Lancet. 2012;380:805–6.
   Google Scholar
• Leibovici L, Paul M, Ezra O. Ethical dilemmas in antibiotic treatment. J Antimicrob Chemother. 2012;67:12–16.
   Google Scholar
• Bigdeli M, Jacobs B, Tomson G, Laing R, Ghaffar A, Dujardin B, et al. Access to medicines from a health system perspective. Health Policy Plan. 2013;28:692–704.
   PubMed Web of Science ®Google Scholar
• Cars O, Hogberg LD, Murray M, Nordberg O, Sivaraman S, Lundborg CS, et al. Meeting the challenge of antibiotic resistance. BMJ. 2008;337:a1438.
   PubMed Web of Science ®Google Scholar
• Tomson G. The impact of global processes on health systems in Europe. Global Health Europe. 2010;2:1–47.
   Google Scholar
• Goossens H, Ferech M, Vander Stichele R, Elseviers M, Group EP. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579–87.
   PubMed Web of Science ®Google Scholar
• Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis. 2005;5:481–93.
   PubMed Web of Science ®Google Scholar
• Newton PN, Green MD, Fernández FM, Day NPJ, White NJ. Counterfeit anti-infective drugs. Lancet Infect Dis. 2006;6:602–13.
   PubMed Web of Science ®Google Scholar
• Planta MB. The role of poverty in antimicrobial resistance. J Am Board Fam Med. 2007;20:533–9.
   Google Scholar
• So AD, Ruiz-Esparza Q, Gupta N, Cars O. 3Rs for innovating novel antibiotics: sharing resources, risks, and rewards. BMJ. 2012;344:e1782.
   PubMedGoogle Scholar
• Laxminarayan R, Heymann DL. Challenges of drug resistance in the developing world. BMJ. 2012;344:e1567.
   PubMed Web of Science ®Google Scholar
• Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet. 2005;365:1175–88.
   PubMed Web of Science ®Google Scholar
• Allegranzi B, Bagheri Nejad S, Combescure C, Graafmans W, Attar H, Donaldson L, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377:228–41.
   PubMed Web of Science ®Google Scholar
• Smith R, Coast J. The true cost of antimicrobial resistance. BMJ. 2013;346:f1493.
   PubMed Web of Science ®Google Scholar
• Okeke IN, Klugman KP, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis. 2005;5:568–80.
   PubMed Web of Science ®Google Scholar
• Ashley EA, Lubell Y, White NJ, Turner P. Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries. Trop Med Int Health. 2011;16:1167–79.
   PubMed Web of Science ®Google Scholar
• Radyowijati A, Haak H. Improving antibiotic use in low-income countries: an overview of evidence on determinants. Soc Sci Med. 2003;57:733–44.
   PubMed Web of Science ®Google Scholar
• Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543.
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Duse A, Wattal C, Zaidi AKM, Wertheim HFL, Sumpradit N, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13:1057–98.
   PubMed Web of Science ®Google Scholar
• Lim YW, Steinhoff M, Girosi F, Holtzman D, Campbell H, Boer R, et al. Reducing the global burden of acute lower respiratory infections in children: the contribution of new diagnostics. Nature. 2006;444:9–18.
   PubMed Web of Science ®Google Scholar
• Morgan DJ, Okeke IN, Laxminarayan R, Perencevich EN, Weisenberg S. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011;11:692–701.
   PubMed Web of Science ®Google Scholar
• Zarb P, Goossens H. Human use of antimicrobial agents. Rev Sci Tech. 2012;31:121–33.
   Google Scholar
• Hawkings NJ, Butler CC, Wood F. Antibiotics in the community: a typology of user behaviours. Patient Educ Couns. 2008;73:146–52.
   PubMed Web of Science ®Google Scholar
• Nordberg P, Stålsby-Lundborg C, Tomson G. Consumers and providers – could they make better use of antibiotics? Int J Risk Safe Med. 2005;17:117–25.
   Google Scholar
• Byarugaba DK. A view on antimicrobial resistance in developing countries and responsible risk factors. Int J Antimicrob Agents. 2004;24:105–10.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Critically important antimicrobials for human medicine: categorization for the development of risk management strategies to contain antimicrobial resistance due to non-human antimicrobial use. Report of the Second WHO Expert Meeting Copenhagen: World Health Organization; 2007.
   Google Scholar
• Bengtsson B, Greko C. Antibiotic resistance—consequences for animal health, welfare, and 3 food production. Upsala J Med Sci. 2014; [Epub ahead of print].
   Google Scholar
• Larsson DGJ. Antibiotics in the environment. Upsala J Med Sci. 2014; [Epub ahead of print].
   Google Scholar
• So AD, Gupta N, Brahmachari SK, Chopra I, Munos B, Nathan C, et al. Towards new business models for R&D for novel antibiotics. Drug Resist Updat. 2011;14:88–94.
   PubMed Web of Science ®Google Scholar
• Levin A, Kaddar M. Role of the private sector in the provision of immunization services in low- and middle-income countries. Health Policy Plan. 2011;26:i4–12.
   PubMed Web of Science ®Google Scholar
• Newton PN, Amin AA, Bird C, Passmore P, Dukes G, Tomson G, et al. The primacy of public health considerations in defining poor quality medicines. PLoS Med. 2011;8:e1001139.
   PubMed Web of Science ®Google Scholar
• Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev. 2011;24:718–33.
   PubMed Web of Science ®Google Scholar
• Grave K, Jensen VF, Odensvik K, Wierup M, Bangen M. Usage of veterinary therapeutic antimicrobials in Denmark, Norway and Sweden following termination of antimicrobial growth promoter use. Prev Vet Med. 2006;75:123–32.
   PubMed Web of Science ®Google Scholar
• Molstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis. 2008;8:125–32.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2013.
   Google Scholar
• World Health Organization Regional Office for Europe. Countries - Romania - Areas of Work. Available at http://www.euro.who.int/en/countries/romania/areas-of-work. accessed 24 November 2013.
   Google Scholar
• Wertheim HF, Chandna A, Vu PD, Pham CV, Nguyen PD, Lam YM, et al. Providing impetus, tools, and guidance to strengthen national capacity for antimicrobial stewardship in Viet Nam. PLoS Med. 2013;10:e1001429.
   Google Scholar
• World Health Organization. The evolving threat of antimicrobial resistance: options for action. Geneva: World Health Organization; 2012.
   Google Scholar
• Pshetizky Y, Naimer S, Shvartzman P. Acute otitis media–a brief explanation to parents and antibiotic use. Fam Pract. 2003;20:417–19.
   Google Scholar
• Suffoletto B, Calabria J, Ross A, Callaway C, Yealy DM. A mobile phone text message program to measure oral antibiotic use and provide feedback on adherence to patients discharged from the emergency department. Acad Emerg Med. 2012;19:949–58.
   Google Scholar
• Nglazi MD, Bekker LG, Wood R, Hussey GD, Wiysonge CS. Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol. Syst Rev. 2013;2:6.
   PubMedGoogle Scholar
• Huttner B, Goossens H, Verheij T, Harbarth S; CHAMP Consortium. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis. 2010;10:17–31.
   PubMed Web of Science ®Google Scholar
• European Commission. Antimicrobial resistance. Special Eurobarometer 338. 2010. Available at http://ec.europa.eu/health/antimicrobial_resistance/docs/ebs_338_en.pdf. accessed 23 November 2013.
   Google Scholar
• Management Sciences for Health. Building local coalitions for containing drug resistance: a guide 2012. Available at http://www1.msh.org/projects/sps/SPS-Documents/upload/AMR-guide-English_FINAL.pdf. accessed 24 November 2013.
   Google Scholar